Patents by Inventor Zohreh Sajjadi

Zohreh Sajjadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucosylceramide synthase inhibitors and therapeutic methods using the same
    Patent number: 11220479
    Abstract: Glucosylceramide synthase inhibitors and compositions containing the same are disclosed. Methods of using the glucosylceramide synthase inhibitors in the treatment of diseases and conditions wherein inhibition of glucosylceramide synthase provides a benefit, like Gaucher disease and Fabry disease, also are disclosed.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: January 11, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Scott D. Larsen, James A. Shayman, Kim Hutchings, Neil Moss, Qin Jiang, Nicholas Mayhew, Emily Freeman, Zohreh Sajjadi Hashemi
  • Azapeptides as CD36 binding compounds
    Patent number: 9708370
    Abstract: An azapeptide compound of Formula I: A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa?)b-B ??I.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: July 18, 2017
    Assignees: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP, VALORISATION HSJ, LIMITED PARTNERSHIP
    Inventors: Huy Ong, Sylvain Chemtob, William Lubell, Florian Sennlaub, Damien Boeglin, Caroline Proulx, Zohreh Sajjadi, David Sabatino
  • Tricyclic compounds and PBK inhibitors containing the same
    Patent number: 9453025
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Grant
    Filed: December 9, 2014
    Date of Patent: September 27, 2016
    Assignee: OncoTherapy Science, Inc.
    Inventors: Yusuke Nakamura, Yo Matsuo, Shoji Hisada, Feryan Ahmed, Raymond Huntley, Zohreh Sajjadi-Hashemi, David M. Jenkins, Robert B. Kargbo, Wenge Cui, Polivina Jolicia F. Gauuan, Joel R. Walker, Helene Decornez, Mahender Gurram
  • AZAPEPTIDES AS CD36 BINDING COMPOUNDS
    Publication number: 20150329591
    Abstract: An azapeptide compound of Formula I: A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa?)b-B
    Type: Application
    Filed: July 28, 2015
    Publication date: November 19, 2015
    Inventors: Huy ONG, Sylvain CHEMTOB, William LUBELL, Florian SENNLAUB, Damien BOEGLIN, Caroline PROULX, Zohreh SAJJADI, David SABATINO
  • Azapeptides as CD36 binding compounds
    Patent number: 9115171
    Abstract: An azapeptide compound of Formula I: A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa?)b-B??I.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: August 25, 2015
    Assignees: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP, VALORISATION HSJ, LIMITED PARTNERSHIP
    Inventors: Huy Ong, Sylvain Chemtob, William Lubell, Florian Sennlaub, Damien Boeglin, Caroline Proulx, Zohreh Sajjadi, David Sabatino
  • Tricyclic Compounds and PBK Inhibitors Containing the Same
    Publication number: 20150183799
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Application
    Filed: December 9, 2014
    Publication date: July 2, 2015
    Inventors: Yusuke NAKAMURA, Matsuo YO, Shoji HISADA, Feryan AHMED, Raymond HUNTLEY, Zohreh SAJJADI-HASHEMI, David M. JENKINS, Robert B. KARGBO, Wenge CUI, Polivina Jolicia F. GAUUAN, Joel R. WALKER, Helene DECORNEZ, Mahender GURRAM
  • Tricyclic compounds and PBK inhibitors containing the same
    Patent number: 8962648
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: February 24, 2015
    Assignee: OncoTherapy Science, Inc.
    Inventors: Yusuke Nakamura, Yo Matsuo, Shoji Hisada, Feryan Ahmed, Raymond Huntley, Zohreh Sajjadi-Hashemi, David M. Jenkins, Robert B. Kargbo, Wenge Cui, Polivina Jolicia F. Gauuan, Joel R. Walker, Helene Decornez, Mahender Gurram
  • AZAPEPTIDES AS CD36 BINDING COMPOUNDS
    Publication number: 20130203686
    Abstract: An azapeptide compound of Formula I: A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa?)b—B??I.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 8, 2013
    Inventors: Huy Ong, Sylvain Chemtob, William Lubell, Florian Sennlaub, Damien Boeglin, Caroline Proulx, Zohreh Sajjadi, David Sabatino
  • TRICYCLIC COMPOUNDS AND PBK INHIBITORS CONTAINING THE SAME
    Publication number: 20130178459
    Abstract: Tricyclic compounds are provided. These compounds are PBK inhibitors, and are useful for the treatment of PBK related diseases, including cancer.
    Type: Application
    Filed: March 29, 2011
    Publication date: July 11, 2013
    Applicant: Oncotherapy Science, Inc.
    Inventors: Yusuke Nakamura, Yo Matsuo, Shoji Hisada, Feryan Ahmed, Raymond Huntley, Zohreh Sajjadi-Hashemi, David M. Jenkins, Robert B. Kargbo, Wenge Cui, Polivina Jolicia F. Gauuan, Joel R. Walker, Helene Decornez, Mahender Gurram
  • Azapeptides as CD36 binding compounds
    Patent number: 8435954
    Abstract: An azapeptide derivative of growth hormone releasing peptide (GHRP) of Formula I: A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa?)b-B which binds to CD 36.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: May 7, 2013
    Assignees: Valorisation-Recherche, Limited Partnership, Valorisation HSJ, Limited Partnership
    Inventors: Huy Ong, Sylvain Chemtob, William Lubell, Florian Sennlaub, Damien Boeglin, Caroline Proulx, Zohreh Sajjadi, David Sabatino
  • AZAPEPTIDES AS CD36 BINDING COMPOUNDS
    Publication number: 20100210566
    Abstract: An azapeptide derivative of growth hormone releasing peptide (GHRP) of Formula I: A-(Xaa)a-N(RA)—N(RB)—C(O)-(Xaa?)b-B which binds to CD 36.
    Type: Application
    Filed: June 18, 2008
    Publication date: August 19, 2010
    Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Huy Ong, Sylvain Chemtob, William Lubell, Florian Sennlaub, Damien Boeglin, Caroline Proulx, Zohreh Sajjadi, David Sabatino